Estradiol alleviated chemotherapy-induced premature ovarian failure by blocking the ferroptosis via activating ESR2/Sirt1/Nrf2 pathway
Biochemical Pharmacology · 2026
DOI: 10.1016/j.bcp.2025.117481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Fengyu Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022 Anhui, China; NHC Key Laboratory of …. Hauptthemen laut MEDLINE: Ferroptosis, Estradiol, NF-E2-Related Factor 2, Primary Ovarian Insufficiency. Die Arbeit nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, University Natural Science Research Project of Anhui Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Premature ovarian failure (POF) is a clinical syndrome characterized by a decline in ovarian function in women before the age of 40. The aim of this study is to investigate the therapeutic effects of estradiol (E2) on POF induced by chemotherapy and elucidate its potential underlying mechanisms. The results showed that E2 treatment increased the ovary index and number of follicles in mice. E2 supplementation inhibited cisplatin induced ferroptosis in mouse ovarian tissue and reversed the downregulation of nuclear factor erythroid 2-related factor 2 (Nrf2), solute carrier family 7 member 11 (SLC7A11), heme oxygenase 1 (HO-1) and glutathione peroxidase 4 (Gpx4) protein expression induced by cisplatin treatment. We also revealed that E2 alleviated cisplatin or RSL3-induced decreases in cell viability and increased lipid peroxidation (LPO) and reactive oxygen species (ROS) levels in KGN and SVOG cells. Moreover, we found that E2 increases Nrf2, SLC7A11, HO-1, and Gpx4 protein levels in vitro. Further studies revealed that E2 activated Sirt1 both in vitro and in vivo. Treating KGN or SVOG cells with the Sirt1 inhibitor EX527 prevented the ability of E2 to inhibit ferroptosis and Nrf2 protein expression. We demonstrated that estrogen receptor beta (ESR2) is involved in the positive regulation of Sirt1 expression. In summary, E2 supplementation alleviates chemotherapy-induced POF by inhibiting ferroptosis through the ESR2/Sirt1/Nrf2pathway activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022 Anhui, China; NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract (Anhui Medical Univer…
- Department of Oncology, Fuyang Hospital of Anhui Medical University, Fuyang 236000, China; NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract (Anhui Medical University), No. 81 Meishan Road, Hefei 23…
- Department of Oncology, Fuyang Hospital of Anhui Medical University, Fuyang 236000, China.
- Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022 Anhui, China; Department of Oncology, Fuyang Hospital of Anhui Medical University, Fuyang 236000, China; N…
Förderung
- National Natural Science Foundation of China
- University Natural Science Research Project of Anhui Province
Zitieren
APA
Zhu, F., Chen, H., Wang, S., Li, J., Zhang, R., Zhang, N., He, Z., Han, K., Cheng, L., & Zhong, F. (2026). Estradiol alleviated chemotherapy-induced premature ovarian failure by blocking the ferroptosis via activating ESR2/Sirt1/Nrf2 pathway. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117481
Vancouver
Zhu F, Chen H, Wang S, Li J, Zhang R, Zhang N, et al. Estradiol alleviated chemotherapy-induced premature ovarian failure by blocking the ferroptosis via activating ESR2/Sirt1/Nrf2 pathway. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2025.117481
BibTeX
@article{Zhu2026,
author = {Zhu, Fengyu and Chen, Hongxu and Wang, Siyuan and Li, Jiaoyu and Zhang, Ruixin and Zhang, Nie and He, Zhuoying and Han, Ke and Cheng, Linghui and Zhong, Fei},
title = {Estradiol alleviated chemotherapy-induced premature ovarian failure by blocking the ferroptosis via activating ESR2/Sirt1/Nrf2 pathway},
journal = {Biochemical Pharmacology},
year = {2026},
doi = {10.1016/j.bcp.2025.117481}
}
EUVIMED